YouTube · Q1 FY2027 · 2026-08-06
CAH · NYSE
Cardinal Health, Inc.
Medical Distribution · United States
USD 233.720.3% daily changeQuote 2026-10-06 · USD
- Market cap (USD)
- US$54.12B
- Trailing P/E
- 32.33x
- Forward P/E
- 16.63x
- Quarterly revenue growth
- 5.8%
- Trailing net margin
- 0.7%
- Indicated dividend yield
- 0.9%
Snapshot 2026-10-06 · Latest financial period 2026-06-30 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.
Next earnings: 2026-11-05 (provider estimate, not issuer-confirmed).
Company background
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Company websiteQ4 FY2026
Go beyond the headline.
Cardinal Health (CAH) Q4 FY2026 Earnings: EPS Guided Up, Cash Guided Down
Published 2026-08-12
Short takes Q4 FY2026
CAH Stock: Cardinal Health Q4 FY2026 Earnings - EPS Up, Cash Down
Watch Short on YouTube
Comparable businesses
CAH peer comparison
Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.
| Metric | CAHCardinal Health, Inc.Snapshot 2026-10-06Financial period: 2026-06-30 | MCKMcKesson CorporationSnapshot 2026-10-06Financial period: 2026-06-30 |
|---|---|---|
| Market capMarket value, converted to USD | US$54.12B | US$107.69B |
| Forward P/EProvider forward earnings estimate | 16.63x | 18.30x |
| EV / EBITDAEnterprise value / trailing EBITDA | 14.02x | 16.45x |
| Revenue growthLatest quarter vs prior-year quarter | 5.8% | 7.7% |
| Operating marginLatest reported quarter | 1.3% | 1.3% |
| Free cash flow yieldTrailing cash flow / market cap | 8.8% | 6.3% |
| Net debt / EBITDANet debt / trailing EBITDA | 1.21x | 0.94x |
| Debt / equityTotal debt / positive book equity | — | — |
| Trailing P/ETrailing twelve-month earnings | 32.33x | 24.76x |
| Price / bookPrice / positive book equity per share | — | — |
| EV / salesEnterprise value / trailing revenue | 0.23x | 0.28x |
| Earnings growthLatest quarter vs prior-year quarter | 68.8% | -17.6% |
| Gross marginTrailing twelve months | 3.8% | 3.6% |
| Net marginTrailing twelve months | 0.7% | 1.1% |
| Return on equityProvider trailing return; positive equity only | — | — |
| Free cash flow marginTrailing free cash flow / revenue | 1.9% | 1.7% |
| Dividend yieldIndicated annual dividend / price | 0.9% | 0.4% |
| Earnings payoutProvider trailing dividend payout | 28.3% | 8.8% |
| Current ratioCurrent assets / current liabilities | 0.88x | 0.89x |
| BetaProvider historical market sensitivity | 0.50 | 0.30 |
YouTube · Q1 FY2027 · 2026-08-06
Comparison methodology & limitations
Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.
Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.
Reported performance
Financial trends
Periods are grouped by their ending calendar year or quarter, not identical fiscal calendars. Exact period-end dates appear in tooltips and reported figures. When reporting currencies differ and a recent captured FX rate is available, money and EPS are normalized to USD for comparison. This is not a historical FX restatement. Gaps are not estimated.
Financial statements load separately from the research page.
Source: . Window ends at the latest available reporting period.
Revenue
Reported figures
Financial data & calculation notes
Standalone charts use the stated reporting currency. When a chart comparison spans currencies, money and EPS can be normalized to USD using a recent captured FX snapshot; this is for comparison only, not a historical FX restatement. Stock-based compensation is noncash. Free cash flow is operating cash flow less capital spending, which may include capitalized software. Missing metrics are not estimated or assumed to be zero. Banking and insurance ratios require industry-specific interpretation. Latest restatements may differ from figures in older episodes.
Market context
Valuation & price history
Adjusted closing price
Price history loads separately.
Price figures
Earnings-multiple scenario
Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.
Starting assumptions, when available, use provider forward estimates as of 2026-10-06. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.
THE RESEARCH RECORD
Research history for CAH
Q4 FY20262026-08-12
Cardinal Health (CAH) Q4 FY2026 Earnings: EPS Guided Up, Cash Guided Down
Presentation · 2026-08-12 · YouTube
Short takes Q4 FY2026
CAH Stock: Cardinal Health Q4 FY2026 Earnings - EPS Up, Cash Down
Watch Short on YouTube
Q3 FY20262026-05-01
CAH Stock: Q3 FY2026 Earnings Analysis
Presentation · 2026-05-01 · YouTube